Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
Journal
Journal for ImmunoTherapy of Cancer
Journal Volume
10
Journal Issue
1
Date Issued
2022
Author(s)
Zucali P.A.
Carthon B.C.
Bauer T.M.
Tucci M.
Italiano A.
Iacovelli R.
Su W.-C.
Massard C.
Saleh M.
Daniele G.
Greystoke A.
Gutierrez M.
Pant S.
Perrino M.
Meng R.
Abbadessa G.
Lee H.
Dong Y.
Chiron M.
Wang R.
Loumagne L.
L?pine L.
De Bono J.
SDGs
Publisher
BMJ Publishing Group
Type
journal article